These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36651874)

  • 1. Vancomycin use for haemodialysis patients-Development of a new dosing protocol.
    Ho E; Gleeson S; Roberts S; Bondesio K; Salmon A
    Nephrology (Carlton); 2023 Apr; 28(4):227-233. PubMed ID: 36651874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Weight Threshold-Based Vancomycin Dosing Protocol for Patients Undergoing Intermittent Hemodialysis.
    Sun LXL; Liu KD; Lynch S; Mistry M; Wise H; Iliescu E
    Can J Hosp Pharm; 2019; 72(5):369-376. PubMed ID: 31692636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Approach to Optimise Therapeutic Vancomycin Dosage in a Haemodialysis Population.
    Gunning H; Taylor G; Smyth A; Mellotte G; Fennell J; Murphy P; Lavin P; Wall C
    Ir Med J; 2016 Oct; 109(9):465. PubMed ID: 28125179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients.
    Maxson R; Pate J; Starr J
    Ren Fail; 2016 Nov; 38(10):1677-1682. PubMed ID: 27756193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An updated vancomycin dosing protocol for initiating therapy in patients undergoing intermittent high-flux hemodialysis.
    Zelenitsky SA; Ariano RE
    Am J Health Syst Pharm; 2022 Jun; 79(12):1006-1010. PubMed ID: 35234825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software.
    Stefani M; Musgrave K; Sevastos J; Penny M; Day RO; Roberts DM
    Nephrology (Carlton); 2023 Oct; 28(10):534-539. PubMed ID: 37394830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring.
    Hartinger JM; Šíma M; Hronová K; Halouzková BA; Szonowská B; Polakovič V; Bednářová V; Hladinová Z; Tesař V; Slanař O
    J Chemother; 2022 May; 34(3):149-156. PubMed ID: 34551680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a Vancomycin Dose-Optimization Protocol in Neonates: Impact on Vancomycin Exposure, Biological Parameters, and Clinical Outcomes.
    Gomez L; Boegler D; Epiard C; Alin L; Arata-Bardet J; Caspar Y; Debillon T; Stanke-Labesque F; Gautier-Veyret E
    Antimicrob Agents Chemother; 2022 May; 66(5):e0219121. PubMed ID: 35465728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosing in chronic high-flux haemodialysis: a systematic review.
    Hui K; Upjohn L; Nalder M; Buising K; Pedagogos E; Nelson C; Kirkpatrick CMJ; Kong DCM
    Int J Antimicrob Agents; 2018 May; 51(5):678-686. PubMed ID: 29284156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of vancomycin use in chronic haemodialysis patients: room for improvement.
    Zvonar R; Natarajan S; Edwards C; Roth V
    Nephrol Dial Transplant; 2008 Nov; 23(11):3690-5. PubMed ID: 18565979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis
.
    Mahmoud LB; Chaabouni Y; Ghozzi H; Feriani H; Hakim A; Kharrat M; Marrakchi C; Sahnoun Z; Jmaa MB; Zeghal K; Hachicha J
    Clin Nephrol; 2017 Oct; 88(10):198-204. PubMed ID: 28793955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
    Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
    J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of Vancomycin Therapeutic Drug Monitoring in Two Multidisciplinary Hospitals in Latvia.
    Mauliņa I; Darbiniece K; Miķelsone-Jansone L; Erts R; Bandere D; Krūmiņa A
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Development of Vancomycin Dosing Schemes to Meet New AUC/MIC Targets in Intermittent Hemodialysis Using Monte Carlo Simulation Techniques.
    Lewis SJ; Mueller BA
    J Clin Pharmacol; 2021 Feb; 61(2):211-223. PubMed ID: 32851685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
    Vandecasteele SJ; De Bacquer D; De Vriese AS
    Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.